Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Small Cap Foreign Biotech -- Ignore unavailable to you. Want to Upgrade?

To: RWReeves who wrote (73)	7/10/2000 3:21:30 AM
From: nigel bates	Read Replies (1) \| Respond to of 363

VERY early buying in PRM.L this morning. Almost back to the price directors bought stock at.... nig

To: RWReeves who wrote (73)	7/11/2000 2:00:59 PM
From: nigel bates	Read Replies (1) \| Respond to of 363

Haven't discovered this one which looks interesting - newscientist.com "...Chromos have developed a way to implant genes into the satellite DNA. They can implant multiple copies of the same gene, and implant genes far larger than is possible in any other "gene shuttle" technique for ferrying DNA into cells. Once modified, the artificial chromosome can be duplicated hundreds of thousands of times. The company says that the amount of protein produced rises in step with the number of gene copies, and that the chromosome does not interfere with natural chromosomes and so should be safer than inserting genes into host DNA. Because the company is about to sell shares on the Canadian stock market, it is barred from talking to the media. But in a prospectus available to the public, Chromos says it plans to insert the chromosomes into cells which will be grown in fermenters to produce beneficial proteins and to genetically engineer animals so that they produce valuable proteins in their milk..."